Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab.
Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, Altmeyer S, Bittenbring JT, Augsberger C, Ilieva-Babinsky K, Haskamp S, Beier F, Lischer C, Vera J, Lührmann A, Bertz S, Völkl S, Jacobs B, Steidl S, Mackensen A, Bruns H. Biedermann A, et al. Among authors: mougiakakos d. Haematologica. 2024 Dec 1;109(12):3928-3940. doi: 10.3324/haematol.2023.284795. Haematologica. 2024. PMID: 38934068 Free PMC article.
CAR T cells for treating autoimmune diseases.
Blache U, Tretbar S, Koehl U, Mougiakakos D, Fricke S. Blache U, et al. Among authors: mougiakakos d. RMD Open. 2023 Nov 23;9(4):e002907. doi: 10.1136/rmdopen-2022-002907. RMD Open. 2023. PMID: 37996128 Free PMC article. Review.
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
Schewe DM, Vogiatzi F, Münnich IA, Zeller T, Windisch R, Wichmann C, Müller K, Bhat H, Felix E, Mougiakakos D, Bruns H, Lenk L, Valerius T, Humpe A, Peipp M, Kellner C. Schewe DM, et al. Among authors: mougiakakos d. Hemasphere. 2024 Feb 22;8(2):e48. doi: 10.1002/hem3.48. eCollection 2024 Feb. Hemasphere. 2024. PMID: 38435424 Free PMC article.
Anti-CD19 CAR T cells for refractory myasthenia gravis.
Haghikia A, Hegelmaier T, Wolleschak D, Böttcher M, Desel C, Borie D, Motte J, Schett G, Schroers R, Gold R, Mougiakakos D. Haghikia A, et al. Among authors: mougiakakos d. Lancet Neurol. 2023 Dec;22(12):1104-1105. doi: 10.1016/S1474-4422(23)00375-7. Lancet Neurol. 2023. PMID: 37977704 No abstract available.
164 results